vs
BYLINE BANCORP, INC.（BY）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是BYLINE BANCORP, INC.的1.8倍（$197.9M vs $112.4M），BYLINE BANCORP, INC.净利率更高（33.4% vs 6.7%，领先26.7%），REPLIGEN CORP同比增速更快（13.6% vs 9.0%），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 6.4%）
Byline Bank是总部位于美国伊利诺伊州芝加哥的银行，为银行控股公司Byline Bancorp, Inc.的核心子公司，同时是全美SBA 7(a)贷款项目的第四大放贷机构，为客户提供专业的银行及融资相关服务。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
BY vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.8倍
$112.4M
营收增速更快
RGEN
高出4.6%
9.0%
净利率更高
BY
高出26.7%
6.7%
两年增速更快
RGEN
近两年复合增速
6.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $112.4M | $197.9M |
| 净利润 | $37.6M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | — | 9.0% |
| 净利率 | 33.4% | 6.7% |
| 营收同比 | 9.0% | 13.6% |
| 净利润同比 | 33.0% | 143.9% |
| 每股收益（稀释后） | $0.83 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BYRGEN
| Q1 26 | $112.4M | — | ||
| Q4 25 | $117.0M | $197.9M | ||
| Q3 25 | $115.7M | $188.8M | ||
| Q2 25 | $110.5M | $182.4M | ||
| Q1 25 | $103.1M | $169.2M | ||
| Q4 24 | $104.7M | $174.1M | ||
| Q3 24 | $101.8M | $154.9M | ||
| Q2 24 | $99.4M | $154.1M |
净利润BYRGEN
| Q1 26 | $37.6M | — | ||
| Q4 25 | $34.5M | $13.3M | ||
| Q3 25 | $37.2M | $14.9M | ||
| Q2 25 | $30.1M | $14.9M | ||
| Q1 25 | $28.2M | $5.8M | ||
| Q4 24 | $30.3M | $-30.3M | ||
| Q3 24 | $30.3M | $-654.0K | ||
| Q2 24 | $29.7M | $3.3M |
毛利率BYRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% |
营业利润率BYRGEN
| Q1 26 | — | — | ||
| Q4 25 | 40.1% | 9.0% | ||
| Q3 25 | 43.1% | 8.9% | ||
| Q2 25 | 35.2% | 7.6% | ||
| Q1 25 | 36.4% | 3.9% | ||
| Q4 24 | 38.6% | -17.7% | ||
| Q3 24 | 39.3% | -5.1% | ||
| Q2 24 | 40.4% | 1.0% |
净利率BYRGEN
| Q1 26 | 33.4% | — | ||
| Q4 25 | 34.1% | 6.7% | ||
| Q3 25 | 32.1% | 7.9% | ||
| Q2 25 | 27.2% | 8.2% | ||
| Q1 25 | 27.4% | 3.4% | ||
| Q4 24 | 34.3% | -17.4% | ||
| Q3 24 | 29.8% | -0.4% | ||
| Q2 24 | 29.9% | 2.2% |
每股收益（稀释后）BYRGEN
| Q1 26 | $0.83 | — | ||
| Q4 25 | $0.77 | $0.24 | ||
| Q3 25 | $0.82 | $0.26 | ||
| Q2 25 | $0.66 | $0.26 | ||
| Q1 25 | $0.64 | $0.10 | ||
| Q4 24 | $0.68 | $-0.55 | ||
| Q3 24 | $0.69 | $-0.01 | ||
| Q2 24 | $0.68 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $198.4M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $1.3B | $2.1B |
| 总资产 | $9.9B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资BYRGEN
| Q1 26 | $198.4M | — | ||
| Q4 25 | $149.1M | $767.6M | ||
| Q3 25 | $259.0M | $748.7M | ||
| Q2 25 | $218.3M | $708.9M | ||
| Q1 25 | $421.3M | $697.2M | ||
| Q4 24 | $563.1M | $757.4M | ||
| Q3 24 | $452.6M | $784.0M | ||
| Q2 24 | $730.5M | $809.1M |
总债务BYRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益BYRGEN
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $2.1B | ||
| Q3 25 | $1.2B | $2.1B | ||
| Q2 25 | $1.2B | $2.1B | ||
| Q1 25 | $1.1B | $2.0B | ||
| Q4 24 | $1.1B | $2.0B | ||
| Q3 24 | $1.1B | $2.0B | ||
| Q2 24 | $1.0B | $2.0B |
总资产BYRGEN
| Q1 26 | $9.9B | — | ||
| Q4 25 | $9.7B | $2.9B | ||
| Q3 25 | $9.8B | $2.9B | ||
| Q2 25 | $9.7B | $2.9B | ||
| Q1 25 | $9.6B | $2.9B | ||
| Q4 24 | $9.5B | $2.8B | ||
| Q3 24 | $9.4B | $2.8B | ||
| Q2 24 | $9.6B | $2.9B |
负债/权益比BYRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流BYRGEN
| Q1 26 | — | — | ||
| Q4 25 | $140.3M | $25.7M | ||
| Q3 25 | $38.3M | $48.1M | ||
| Q2 25 | $16.3M | $28.6M | ||
| Q1 25 | $27.1M | $15.0M | ||
| Q4 24 | $175.2M | $39.2M | ||
| Q3 24 | $19.8M | $49.3M | ||
| Q2 24 | $40.1M | $42.2M |
自由现金流BYRGEN
| Q1 26 | — | — | ||
| Q4 25 | $136.3M | $17.6M | ||
| Q3 25 | $38.0M | $43.4M | ||
| Q2 25 | $15.2M | $21.5M | ||
| Q1 25 | $25.0M | $11.4M | ||
| Q4 24 | $171.2M | $33.6M | ||
| Q3 24 | $19.1M | $42.3M | ||
| Q2 24 | $39.4M | $37.4M |
自由现金流率BYRGEN
| Q1 26 | — | — | ||
| Q4 25 | 116.5% | 8.9% | ||
| Q3 25 | 32.8% | 23.0% | ||
| Q2 25 | 13.7% | 11.8% | ||
| Q1 25 | 24.3% | 6.8% | ||
| Q4 24 | 163.5% | 19.3% | ||
| Q3 24 | 18.8% | 27.3% | ||
| Q2 24 | 39.7% | 24.3% |
资本支出强度BYRGEN
| Q1 26 | — | — | ||
| Q4 25 | 3.4% | 4.1% | ||
| Q3 25 | 0.3% | 2.5% | ||
| Q2 25 | 1.0% | 3.9% | ||
| Q1 25 | 2.0% | 2.1% | ||
| Q4 24 | 3.8% | 3.2% | ||
| Q3 24 | 0.6% | 4.5% | ||
| Q2 24 | 0.7% | 3.1% |
现金转化率BYRGEN
| Q1 26 | — | — | ||
| Q4 25 | 4.06× | 1.93× | ||
| Q3 25 | 1.03× | 3.23× | ||
| Q2 25 | 0.54× | 1.92× | ||
| Q1 25 | 0.96× | 2.57× | ||
| Q4 24 | 5.78× | — | ||
| Q3 24 | 0.65× | — | ||
| Q2 24 | 1.35× | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
